Urolithiasis Active Not Recruiting Phase 4 Trials for Sildenafil (DB00203)

Also known as: Urolithiases / Urolithiasis (N20-N23) / Urolith

IndicationStatusPhase
DBCOND0032691 (Urolithiasis)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02519153Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral StonesTreatment